CABLINE 0.5

INDICATIONS:

• Lowers prolactin levels, improves fertility
• A potent dopamine receptor agonist; reduces prolactin levels
• Effective in hyperprolactinemic hypogonadism
• A first-choice treatment due to its efficacy and superior tolerability
• Corrects hyperprolactinemia and restores the ovulatory cycle more effectively than bromocriptine in women with hyperprolactinemic amenorrhea
• Cabergoline causes fewer adverse effects compared to bromocriptine, which requires high doses to achieve clinical improvement and a reduction in prolactinomas

DOSAGE:

Suppression of lactation after childbirth (stillbirth) and (post-abortion, as a second-line treatment)
2 tablets as a single dose, to be taken within 24 hours of delivery.
Cessation of breastfeeding (weaning): 1/2 tablet, morning and evening for 2 days (total of 2 tablets).
Consequences of excess prolactin (hyperprolactinemia): 1 tablet per week. After 4 weeks of treatment, a blood prolactin test will allow the doctor to adjust the dosage.